# cCeLL - In vivo (K260315): 510(k) cleared for VPIX Medical, Inc.

**Predicate Speed & CAPA Advisory Opportunity Score:** 61/100

| Field | Value |
|---|---|
| Record | 510(k) clearance |
| 510(k) number | K260315 |
| Device | cCeLL - In vivo |
| Applicant | VPIX Medical, Inc. |
| Specialty / panel | Neurology |
| Product code | GWG |
| Device class | 2 |
| Clearance type | Traditional |
| Decision | Substantially Equivalent |
| Received | 2026-01-30 |
| Decision date | 2026-10-16 |
| Review time (days) | 259 |
| Third-party review | No |
| Applicant location | Daejeon, KR |

## Why this score
- A long 259-day review suggests additional-information requests: a firm likely to value regulatory help next time.
- Posted 21 days ago.

Source: U.S. FDA openFDA (510(k) clearances and device enforcement reports) (https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K260315). Last refreshed: 2026-11-05T14:35:15.671Z.
Data from the FDA openFDA API, which may lag official FDA databases. Informational only; not regulatory or legal advice.